ZYNE

Zynerba Pharmaceuticals, Inc

Delisted

ZYNE was delisted on the 10th of October, 2023.

41 hedge funds and large institutions have $1.74M invested in Zynerba Pharmaceuticals, Inc in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 5 closing their positions.

Holders
41
Holders Change
-3
Holders Change %
-6.82%
% of All Funds
0.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
7
Reduced
12
Closed
5
Calls
$11K
Puts
Net Calls
+$11K
Net Calls Change
+$1K
Name Market Value Shares Shares
Change
Shares
Change %
KFI
26
Key Financial Inc
Pennsylvania
$2.45K 7,500
TWC
27
TD Waterhouse Canada
Ontario, Canada
$1.73K 4,145 +4,145 New
NFSG
28
Newbridge Financial Services Group
Florida
$1.5K 4,610 -1,465 -24%
Group One Trading
29
Group One Trading
Illinois
$1.49K 4,559
FCMT
30
Founders Capital Management (Texas)
Texas
$652 2,000
RhumbLine Advisers
31
RhumbLine Advisers
Massachusetts
$262 805 +805 New
SIS
32
Sound Income Strategies
Florida
$114 350
Bank of America
33
Bank of America
North Carolina
$57 173 -27 -14%
KTC
34
Kistler-Tiffany Companies
Pennsylvania
$33 100
HI
35
Harbour Investments
Wisconsin
$33 100
HPC
36
HM Payson & Co
Maine
$17 50
Fidelity Investments
37
Fidelity Investments
Massachusetts
$8 25 -150 -86%
IA
38
IFP Advisors
Florida
$7 23 +23 New
GIA
39
GHP Investment Advisors
Colorado
$1 1
VF
40
Virtu Financial
New York
-32,386 Closed
HF
41
HRT Financial
New York
-19,760 Closed
Simplex Trading
42
Simplex Trading
Illinois
-2,274 Closed
CFGS
43
Concourse Financial Group Securities
Alabama
-501 Closed
HNB
44
Huntington National Bank
Ohio
-217 Closed
LC
45
Lindbrook Capital
California
$0 1
IHWM
46
Iron Horse Wealth Management
Iowa
$0 1
Citadel Advisors
47
Citadel Advisors
Florida